Arthur F Ryan Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Arthur F Ryan is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,682 shares of REGN, which is worth approximately $20.4 Million. The most recent transaction as insider was on Sep 06, 2022, when has been sold 100 shares (Common Stock) at a price of $582.03 per share, resulting in proceeds of $58,203. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K

1.67% 3M change

5.18% 12M change

Total Value Held $20.4 Million

ARTHUR F RYAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 06 2022	SELL Open market or private sale	$58,203 $582.03 p/Share	100 Reduced 0.51%	19,582 Common Stock
Aug 04 2022	SELL Bona fide gift	-	2,500 Reduced 11.27%	19,682 Common Stock
Aug 04 2022	SELL Open market or private sale	$6,496,330 $621.48 p/Share	10,453 Reduced 34.69%	19,682 Common Stock
Aug 04 2022	BUY Exercise of conversion of derivative security	$4,312,699 $412.58 p/Share	10,453 Added 33.14%	21,092 Common Stock
May 02 2022	SELL Open market or private sale	$65,058 $650.58 p/Share	100 Reduced 0.45%	22,182 Common Stock
Apr 01 2022	SELL Open market or private sale	$69,317 $693.17 p/Share	100 Reduced 0.45%	22,282 Common Stock
Mar 01 2022	SELL Open market or private sale	$61,547 $615.47 p/Share	100 Reduced 0.44%	22,382 Common Stock
Feb 01 2022	SELL Open market or private sale	$60,604 $606.04 p/Share	100 Reduced 0.44%	22,482 Common Stock
Jan 03 2022	SELL Open market or private sale	$62,507 $625.07 p/Share	100 Reduced 0.44%	22,391 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	191 Added 0.84%	22,582 Common Stock
Dec 01 2021	SELL Open market or private sale	$63,648 $636.48 p/Share	100 Reduced 0.44%	22,491 Common Stock
Nov 16 2021	SELL Bona fide gift	-	500 Reduced 2.17%	22,591 Common Stock
Nov 01 2021	SELL Open market or private sale	$64,292 $642.92 p/Share	100 Reduced 0.43%	23,091 Common Stock
Oct 01 2021	SELL Open market or private sale	$56,944 $569.44 p/Share	100 Reduced 0.43%	23,191 Common Stock
Sep 01 2021	SELL Open market or private sale	$67,855 $678.55 p/Share	100 Reduced 0.43%	23,291 Common Stock
Aug 02 2021	SELL Open market or private sale	$57,648 $576.48 p/Share	100 Reduced 0.43%	23,391 Common Stock
Jul 01 2021	SELL Open market or private sale	$56,235 $562.35 p/Share	100 Reduced 0.42%	23,491 Common Stock
Jun 14 2021	SELL Open market or private sale	$52,551 $525.51 p/Share	100 Reduced 0.42%	23,591 Common Stock
Feb 01 2021	SELL Open market or private sale	$50,782 $507.82 p/Share	100 Reduced 0.42%	23,691 Common Stock
Jan 04 2021	SELL Open market or private sale	$48,454 $484.54 p/Share	100 Reduced 0.42%	23,543 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	248 Added 1.03%	23,791 Common Stock
Dec 01 2020	SELL Open market or private sale	$52,000 $520.0 p/Share	100 Reduced 0.42%	23,643 Common Stock
Nov 02 2020	SELL Open market or private sale	$54,892 $548.92 p/Share	100 Reduced 0.42%	23,743 Common Stock
Oct 01 2020	SELL Open market or private sale	$55,951 $559.51 p/Share	100 Reduced 0.35%	28,343 Common Stock
May 06 2020	SELL Bona fide gift	-	2,000 Reduced 7.59%	24,343 Common Stock

Also insider at

CFG

CITIZENS FINANCIAL GROUP INC Financial Services

Director

AFR

Arthur F Ryan

Director

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account